InvestorsHub Logo
Followers 87
Posts 1159
Boards Moderated 0
Alias Born 09/10/2017

Re: pgsd post# 653272

Tuesday, 12/05/2023 1:39:02 AM

Tuesday, December 05, 2023 1:39:02 AM

Post# of 700401
pgsd, there was so much misleading information about the DCVax trial because the authors referenced the outdated “First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma” from the Journal of Translational Medicine in 2018. See the footnote:
80.Liau   LM, Ashkan   K, Tran   DD, et al. . First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. J Transl Med. 2018;16(1):142. https://doi.org/10.1186/s12967-018-1507-6

This deception was likely intentional because when you look at the history of this article, it shows:

Article history
Received: 24 August 2023
Accepted: 15 November 2023
Published: 04 December 2023

It seems extremely difficult to believe that the authors did not know about the final results of the trial published in JAMA Oncology in November 2022, which would make the deception particularly egregious in my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News